Trials / Recruiting
RecruitingNCT05835518
An Observational, Prospective Study to Assess the Efficacy and Safety of Adalloce in Patients With RA and AS
An Observational, Prospective Study to Assess the Efficacy and Safety of Adalloce in Patients With Rheumatoid Arthritis and Ankylosing Spondylitis
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- Yuhan Corporation · Industry
- Sex
- All
- Age
- 19 Years – 74 Years
- Healthy volunteers
- Not accepted
Summary
This Study is to Assess the Efficacy and Safety of Adalloce in Patients With Rheumatoid Arthritis and Ankylosing Spondylitis, An Observational, Prospective Study
Conditions
Timeline
- Start date
- 2023-01-26
- Primary completion
- 2025-12-31
- Completion
- 2026-08-01
- First posted
- 2023-04-28
- Last updated
- 2023-05-09
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05835518. Inclusion in this directory is not an endorsement.